GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes
To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell Carcinoma
Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway
† Study has passed its completion date and status has not been verified in more than two years.